Pharmaceutical giant Bristol Myers Squibb has leased up the remaining portion of the nearly 480,000-square-foot life science building at DivcoWest’s Cambridge Crossing campus.
BMS expanded its initial 360,000-square-foot lease at DivcoWest’s 250 Water St. with an additional 113,000 square feet. The building is slated to deliver in 2022. Financial terms of the lease weren’t disclosed.
Cambridge Crossing was acquired by San Francisco-based DivcoWest for $291 million in 2015 and will also include 11 acres of open space as well as more than 2,400 residential units and retail space. The campus is located alongside the currently under-construction MBTA Green Line, which will include two new stops near the neighborhood.
David Cohen is Southeast Editorial Director at Connect Commercial Real Estate. David is a media veteran with more than 10 years of experience in journalism, copywriting and communications across a variety of roles.
Email the Author
Reach over 250,000 Commercial Real Estate Professionals with Connect
Connect CRE reaches the top commercial real estate players nationwide and across all property types, offering you a variety of ways to showcase your team, your expertise and your brand to CRE decision makers.
The home for CRE news and everything you need to stay informed on deals, trends, and transactions, providing a platform to get your brand in front of your target audience.
Daily CRE Emails
Reaching over 150,000 inboxes across the nation every day, Connect’s Daily News emails provide advertising opportunities specific to your market.
Bi-Weekly Property Sector Emails
Focus your advertising on emails dedicated to your property sector and stay visible to current and potential clients.
Position your team as experts in your field with content created by Connect’s editorial team and published on Connect’s news emails. Showcase your intelligence and broaden your reach.